High-quality medicines to treat a range of conditions
In response to the changing needs of the people we serve, we continuously develop our range of medicines, with a focus on differentiated products and delivery systems. Currently, we manufacture hundreds of generic medicines in the US.
Related news
Hikma launches Palonosetron Hydrochloride Injection
29 March 2018
Hikma has launched Ritonavir Tablets USP
20 March 2018
Patron of The Prince’s Trust
19 March 2018